Mixed Phenotype Acute Leukemia with BCL11B Copy Gain: What is the Best
Strategy?
- Jinjun Cheng
, - Keri Toner,
- Reuven Schore
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Jinjun Cheng
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Children's National Hospital Center for Cancer and Blood Disorders
Corresponding Author:jcheng2@childrensnational.org
Author ProfileKeri Toner
Children's National Hospital Center for Cancer and Blood Disorders
Author ProfileReuven Schore
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Children's National Hospital Center for Cancer and Blood Disorders
Author Profile02 May 2023Submitted to Pediatric Blood & Cancer 02 May 2023Submission Checks Completed
02 May 2023Assigned to Editor
03 May 2023Review(s) Completed, Editorial Evaluation Pending
08 May 2023Editorial Decision: Accept